Clinical Study
Transcatheter Arterial Infusion of Autologous CD133+ Cells for Diabetic Peripheral Artery Disease
Table 4
VEGF and IL-6 level before and after treatment.
| | CD133+ | Control | |
| VEGF (pg/mL) | Before treatment | 69.65 ± 4.43 | 71.68 ± 5.99 | 0.166 | 1 w | 79.01 ± 7.75 | 74.65 ± 6.74 | 0.034 | 2 w | 82.45 ± 4.74 | 74.07 ± 8.00 | 0.000 | 4 w | 78.61 ± 5.04 | 72.88 ± 6.64 | 0.001 |
| IL-6 (pg/mL) | Before treatment | 124.53 ± 19.94 | 114.24 ± 25.79 | 0.109 | 1 w | 98.66 ± 17.85 | 111.16 ± 21.60 | 0.026 | 2 w | 71.00 ± 25.19 | 96.25 ± 16.98 | 0.000 | 4 w | 81.22 ± 20.22 | 101.16 ± 22.27 | 0.001 |
|
|
w: week.
|